Insider Shareholders with Direct Ownership of Lexaria Bioscience Corp. (LEXX)
This section provides a comprehensive overview of the insiders with direct ownership of Lexaria Bioscience Corp. (LEXX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Lexaria Bioscience Corp. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Christopher Bunka
Director |
100,000 | 0 | 373,543 $310,040 | 1 |
Jan 07, 2025
Added 21.12%
|
|
Richard Christopher
Chief Executive Officer |
65,000 | 0 | 65,000 $53,950 | 3 |
Jul 29, 2025
Added 18.75%
|
|
William Edward Mc Kechnie
Director |
5,000 | 0 | 18,191 $15,098 | 1 |
Jul 29, 2025
Added 21.56%
|
|
Albert L Reese Jr
Director |
10,000 | 0 | 10,917 $9,061 | 4 |
May 24, 2022
Added 31.41%
|
|
John Martin Docherty
President & CSO |
5,376 | 0 | 5,376 $4,462 | 1 |
Jul 29, 2025
Added 50.0%
|
|
Catherine C. Turkel
Director |
3,100 | 0 | 3,100 $2,573 | 2 |
Aug 12, 2024
Added 34.04%
|
|
Gregory Downey
Chief Financial Officer |
121 | 0 | 1,954 $1,621 | 1 |
Oct 14, 2022
Added 5.83%
|
|
Vanessa Carle
Secretary |
3,250 | 2,567 | 750 $622 | 3 |
Jul 29, 2025
Added 50.0%
|